A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C

Marilyn Huckans, Bret Fuller, Viva Wheaton, Sarah Jaehnert, Carilyn Ellis, Michael Kolessar, Daniel Kriz, Jeanne Renee Anderson, Kristin Berggren, Hannah Olavarria, Anna W. Sasaki, Michael Chang, Kenneth D. Flora, Jennifer Loftis

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: To prospectively evaluate for changes in objective cognitive performance (attention, memory, and executive function) and psychiatric symptom severity (depression, anxiety, fatigue, and pain) in patients before, during and after interferon-alpha based therapy (IFN) for chronic hepatitis C virus infection (HCV). Methods: 33 HCV. + adults were evaluated two months before IFN initiation (baseline), three months into IFN, and six months following IFN termination (IFN. + Group). 31 HCV. + adults who did not undergo IFN therapy were evaluated at baseline and six months later (IFN. - Group). At each evaluation, participants completed the Neuropsychological Assessment Battery (NAB) Attention, Memory and Executive Functions Modules, the Beck Depression Inventory, Second Edition (BDI), Generalized Anxiety Disorder Inventory (GADI), Fatigue Severity Scale (FSS), and Brief Pain Inventory (BPI). Results: Compared with the IFN. - Group, the IFN. + Group experienced significantly (p.

Original languageEnglish (US)
Pages (from-to)184-192
Number of pages9
JournalJournal of Psychosomatic Research
Volume78
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Chronic Hepatitis C
Virus Diseases
Interferon-alpha
Hepacivirus
Cognition
Psychiatry
Longitudinal Studies
Executive Function
Equipment and Supplies
Fatigue
Depression
Pain
Anxiety Disorders
Therapeutics
Anxiety

Keywords

  • Anxiety
  • Cognition
  • Depression
  • Fatigue
  • Hepatitis c
  • Interferon
  • Pain

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Medicine(all)

Cite this

A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C. / Huckans, Marilyn; Fuller, Bret; Wheaton, Viva; Jaehnert, Sarah; Ellis, Carilyn; Kolessar, Michael; Kriz, Daniel; Anderson, Jeanne Renee; Berggren, Kristin; Olavarria, Hannah; Sasaki, Anna W.; Chang, Michael; Flora, Kenneth D.; Loftis, Jennifer.

In: Journal of Psychosomatic Research, Vol. 78, No. 2, 01.02.2015, p. 184-192.

Research output: Contribution to journalArticle

Huckans, M, Fuller, B, Wheaton, V, Jaehnert, S, Ellis, C, Kolessar, M, Kriz, D, Anderson, JR, Berggren, K, Olavarria, H, Sasaki, AW, Chang, M, Flora, KD & Loftis, J 2015, 'A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C', Journal of Psychosomatic Research, vol. 78, no. 2, pp. 184-192. https://doi.org/10.1016/j.jpsychores.2014.07.020
Huckans, Marilyn ; Fuller, Bret ; Wheaton, Viva ; Jaehnert, Sarah ; Ellis, Carilyn ; Kolessar, Michael ; Kriz, Daniel ; Anderson, Jeanne Renee ; Berggren, Kristin ; Olavarria, Hannah ; Sasaki, Anna W. ; Chang, Michael ; Flora, Kenneth D. ; Loftis, Jennifer. / A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C. In: Journal of Psychosomatic Research. 2015 ; Vol. 78, No. 2. pp. 184-192.
@article{0d5f9a1ba444482eb8a84a1d73119f99,
title = "A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C",
abstract = "Objective: To prospectively evaluate for changes in objective cognitive performance (attention, memory, and executive function) and psychiatric symptom severity (depression, anxiety, fatigue, and pain) in patients before, during and after interferon-alpha based therapy (IFN) for chronic hepatitis C virus infection (HCV). Methods: 33 HCV. + adults were evaluated two months before IFN initiation (baseline), three months into IFN, and six months following IFN termination (IFN. + Group). 31 HCV. + adults who did not undergo IFN therapy were evaluated at baseline and six months later (IFN. - Group). At each evaluation, participants completed the Neuropsychological Assessment Battery (NAB) Attention, Memory and Executive Functions Modules, the Beck Depression Inventory, Second Edition (BDI), Generalized Anxiety Disorder Inventory (GADI), Fatigue Severity Scale (FSS), and Brief Pain Inventory (BPI). Results: Compared with the IFN. - Group, the IFN. + Group experienced significantly (p.",
keywords = "Anxiety, Cognition, Depression, Fatigue, Hepatitis c, Interferon, Pain",
author = "Marilyn Huckans and Bret Fuller and Viva Wheaton and Sarah Jaehnert and Carilyn Ellis and Michael Kolessar and Daniel Kriz and Anderson, {Jeanne Renee} and Kristin Berggren and Hannah Olavarria and Sasaki, {Anna W.} and Michael Chang and Flora, {Kenneth D.} and Jennifer Loftis",
year = "2015",
month = "2",
day = "1",
doi = "10.1016/j.jpsychores.2014.07.020",
language = "English (US)",
volume = "78",
pages = "184--192",
journal = "Journal of Psychosomatic Research",
issn = "0022-3999",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C

AU - Huckans, Marilyn

AU - Fuller, Bret

AU - Wheaton, Viva

AU - Jaehnert, Sarah

AU - Ellis, Carilyn

AU - Kolessar, Michael

AU - Kriz, Daniel

AU - Anderson, Jeanne Renee

AU - Berggren, Kristin

AU - Olavarria, Hannah

AU - Sasaki, Anna W.

AU - Chang, Michael

AU - Flora, Kenneth D.

AU - Loftis, Jennifer

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Objective: To prospectively evaluate for changes in objective cognitive performance (attention, memory, and executive function) and psychiatric symptom severity (depression, anxiety, fatigue, and pain) in patients before, during and after interferon-alpha based therapy (IFN) for chronic hepatitis C virus infection (HCV). Methods: 33 HCV. + adults were evaluated two months before IFN initiation (baseline), three months into IFN, and six months following IFN termination (IFN. + Group). 31 HCV. + adults who did not undergo IFN therapy were evaluated at baseline and six months later (IFN. - Group). At each evaluation, participants completed the Neuropsychological Assessment Battery (NAB) Attention, Memory and Executive Functions Modules, the Beck Depression Inventory, Second Edition (BDI), Generalized Anxiety Disorder Inventory (GADI), Fatigue Severity Scale (FSS), and Brief Pain Inventory (BPI). Results: Compared with the IFN. - Group, the IFN. + Group experienced significantly (p.

AB - Objective: To prospectively evaluate for changes in objective cognitive performance (attention, memory, and executive function) and psychiatric symptom severity (depression, anxiety, fatigue, and pain) in patients before, during and after interferon-alpha based therapy (IFN) for chronic hepatitis C virus infection (HCV). Methods: 33 HCV. + adults were evaluated two months before IFN initiation (baseline), three months into IFN, and six months following IFN termination (IFN. + Group). 31 HCV. + adults who did not undergo IFN therapy were evaluated at baseline and six months later (IFN. - Group). At each evaluation, participants completed the Neuropsychological Assessment Battery (NAB) Attention, Memory and Executive Functions Modules, the Beck Depression Inventory, Second Edition (BDI), Generalized Anxiety Disorder Inventory (GADI), Fatigue Severity Scale (FSS), and Brief Pain Inventory (BPI). Results: Compared with the IFN. - Group, the IFN. + Group experienced significantly (p.

KW - Anxiety

KW - Cognition

KW - Depression

KW - Fatigue

KW - Hepatitis c

KW - Interferon

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=84920878851&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920878851&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychores.2014.07.020

DO - 10.1016/j.jpsychores.2014.07.020

M3 - Article

C2 - 25219976

AN - SCOPUS:84920878851

VL - 78

SP - 184

EP - 192

JO - Journal of Psychosomatic Research

JF - Journal of Psychosomatic Research

SN - 0022-3999

IS - 2

ER -